Hamster CHO Matrix metalloproteinase-19 (MMP-19) ELISA Kit
Matrix metalloproteinase-19 (MMP-19) is a member of the MMP family of zinc-dependent endopeptidases that remodel the extracellular matrix (ECM). Unlike many other MMPs that are only expressed in response to injury or disease, MMP-19 is constitutively expressed in many tissues, including keratinocytes, endothelial cells, and fibroblasts. ([PubMed][1]) Functionally, MMP-19 can degrade a variety of ECM components (e.g., type IV collagen, fibronectin, nidogen) and has both proteolytic and non-proteolytic roles, influencing cell migration, proliferation, and tissue remodeling. ([Paginas Personales UNAM][2])
More intriguingly, MMP-19 has been implicated in both **pro-angiogenic** and **anti-angiogenic** processes. For example, it can generate angiostatin-like fragments from plasminogen, which inhibit endothelial proliferation and capillary formation, suggesting a regulatory role in vascular remodeling. ([PubMed][3]) In disease contexts, dysregulation of MMP-19 has been linked to cancer (e.g., higher expression in non-small cell lung cancer correlates with invasiveness and poor prognosis) ([PMC][4]), as well as fibrosis: in idiopathic pulmonary fibrosis (IPF), MMP-19 appears to protect against excessive fibrotic progression by promoting epithelial wound healing and inducing prostaglandin-related pathways. ([PMC][5])
In animal models, genetic deletion of MMP-19 has yielded important insights: MMP-19–deficient mice exhibit worsened lung fibrosis in response to bleomycin, highlighting its reparative role, ([PMC][5]) but also display altered immune responses (e.g., in colitis, MMP-19 loss leads to worse inflammation due to impaired macrophage migration and chemokine processing).
This Hamster CHO Matrix metalloproteinase-19 (MMP-19) ELISA Kit is manufactured in USA by Eagle Biosciences.
Related products
